Author

Jing Cheng

Institutions: Mayo Clinic, University of Pittsburgh

Observed institutions: Mayo Clinic, University of Pittsburgh

OpenAlex ID: A5049444831

A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma

2025 · Heejae Kang, Lisa M. Maurer, et al. · Journal of Clinical Investigation · 7

MicroRNAS DOWNREGULATE TUMOR SUPPRESSOR GRK2 IN MALT1-DEPENDENT DIFFUSE LARGE B-CELL LYMPHOMA

2025 · Jing Cheng, Mei Smyers, et al. · Leukemia Research

GRK2, an Inhibitor of MALT1-Dependent Oncogenic Signaling, Is Downregulated By microRNA in ABC-DLBCL

2023 · Jing Cheng, Mei Smyers, et al. · Blood

Abstract A18: GRK2, an inhibitor of MALT1-dependent oncogenic signaling, is downregulated by microRNA in ABC-DLBCL

2022 · Jing Cheng, Mei Smyers, et al. · Blood Cancer Discovery

Faculty Opinions recommendation of Principles of dimer-specific gene regulation revealed by a comprehensive characterization of NF-κB family DNA binding.

2012 · Larry Kane, Jing Cheng · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

Faculty Opinions recommendation of AKT promotes rRNA synthesis and cooperates with c-MYC to stimulate ribosome biogenesis in cancer.

2011 · Larry Kane, Jing Cheng · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

Works count: 6

Citation count: 7

H-index: 1

I10-index: